NASDAQ:TOI Oncology Institute (TOI) Stock Price, News & Analysis $0.34 -0.01 (-2.43%) (As of 10:47 AM ET) Add Compare Share Share Today's Range$0.33▼$0.3650-Day Range$0.33▼$0.5652-Week Range$0.31▼$2.66Volume23,981 shsAverage Volume155,142 shsMarket Capitalization$25.14 millionP/E RatioN/ADividend YieldN/APrice Target$2.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Oncology Institute alerts: Email Address Oncology Institute MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside648.5% Upside$2.50 Price TargetShort InterestHealthy0.70% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.45Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.63) to ($0.35) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.52 out of 5 starsMedical Sector476th out of 924 stocksOffices & Clinics Of Medical Doctors Industry4th out of 8 stocks 3.5 Analyst's Opinion Consensus RatingOncology Institute has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageOncology Institute has received no research coverage in the past 90 days.Read more about Oncology Institute's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.70% of the float of Oncology Institute has been sold short.Short Interest Ratio / Days to CoverOncology Institute has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Oncology Institute has recently decreased by 15.75%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldOncology Institute does not currently pay a dividend.Dividend GrowthOncology Institute does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TOI. Previous Next 1.4 News and Social Media Coverage News SentimentOncology Institute has a news sentiment score of -0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Oncology Institute this week, compared to 3 articles on an average week.MarketBeat Follows2 people have added Oncology Institute to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Oncology Institute insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.50% of the stock of Oncology Institute is held by insiders.Percentage Held by InstitutionsOnly 36.86% of the stock of Oncology Institute is held by institutions.Read more about Oncology Institute's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Oncology Institute are expected to grow in the coming year, from ($0.63) to ($0.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Oncology Institute is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Oncology Institute is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOncology Institute has a P/B Ratio of 0.43. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Oncology Institute's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.You need to check out the full story right here. About Oncology Institute Stock (NASDAQ:TOI)The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.Read More TOI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TOI Stock News HeadlinesAugust 16, 2024 | msn.com6 little changes in everyday routine reduce the risk of cancerAugust 16, 2024 | msn.comU of I getting almost $33M in cancer research fundsAugust 22, 2024 | DTI (Ad)Air Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.August 15, 2024 | msn.comRun organised at Besant Nagar to spread cancer awarenessAugust 15, 2024 | latimes.comUSC Norris Comprehensive Cancer Center to Open Radiation Oncology and Imaging Center in Newport BeachAugust 14, 2024 | msn.comRole of inflammation in gastrointestinal tumor developmentAugust 14, 2024 | seekingalpha.comThe Oncology Institute, Inc. (TOI) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | msn.comStir in govt hospitals across country against Kolkata doctor rape-murder, services hit as doctors ask for CBI inquiryAugust 22, 2024 | DTI (Ad)Air Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.August 12, 2024 | msn.com‘Lifestyle changes can curb cervical, breast cancers’August 9, 2024 | msn.comAACR CEO Dr. Margaret Foti honored as 2024 Beacon Award recipient for leadership in oncologyAugust 8, 2024 | msn.comBengaluru's Kidwai Memorial Institute of Oncology achieves 92 successful bone marrow transplants in 18 monthsAugust 8, 2024 | msn.comResearchers develop pioneering immunotherapy for aggressive brain cancerAugust 7, 2024 | msn.comCancer Screening Costs Over $43 Billion a Year in the U.S., Study EstimatesAugust 6, 2024 | washingtonpost.comI’m an oncologist. Here’s what I do to reduce my own cancer risk.August 6, 2024 | nytimes.comStudy Puts a $43 Billion Yearly Price Tag on Cancer ScreeningAugust 5, 2024 | msn.comProstate Cancer: What you need to knowAugust 5, 2024 | msn.comBreast cancer: Rising incidence and awarenessSee More Headlines Receive TOI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/13/2024Today8/22/2024Next Earnings (Estimated)11/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryHealthcare Current SymbolNASDAQ:TOI CUSIPN/A CIK1799191 Webtheoncologyinstitute.com Phone562-735-3226FaxN/AEmployees660Year FoundedN/APrice Target and Rating Average Stock Price Target$2.50 High Stock Price Target$2.50 Low Stock Price Target$2.50 Potential Upside/Downside+622.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-83,070,000.00 Net Margins-20.28% Pretax Margin-21.31% Return on Equity-109.10% Return on Assets-32.26% Debt Debt-to-Equity Ratio2.14 Current Ratio3.09 Quick Ratio2.83 Sales & Book Value Annual Sales$361.07 million Price / Sales0.07 Cash FlowN/A Price / Cash FlowN/A Book Value$0.77 per share Price / Book0.45Miscellaneous Outstanding Shares74,438,000Free Float67,366,000Market Cap$25.76 million OptionableNot Optionable Beta0.63 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesMr. Richard Alan Barasch (Age 70)Chairman of the Board Dr. Daniel Virnich FACHE (Age 45)M.D., MBA, Chief Executive Officer Comp: $614.62kMr. Mihir Arunkumar Shah CPA (Age 46)Chief Financial Officer Comp: $505.13kDr. Yale D. Podnos F.A.C.S. (Age 52)M.D., M.P.H., Chief Medical Officer Comp: $535.36kMr. Jeremy N. Castle M.B.A. (Age 40)Chief Operations Officer Mr. Mark Hueppelsheuser Esq.General CounselMr. Jordan McInerneyChief Development OfficerMore ExecutivesKey CompetitorsQuipt Home MedicalNASDAQ:QIPTEUDA HealthNASDAQ:EUDABurning Rock BiotechNASDAQ:BNRPono Capital TwoNASDAQ:PTWOEnzo BiochemNYSE:ENZView All CompetitorsInsiders & InstitutionsRenaissance Technologies LLCBought 199,300 shares on 8/9/2024Ownership: 0.456%Tiff Advisory Services LLCBought 995,280 shares on 8/7/2024Ownership: 1.906%Havencrest Healthcare PartnersSold 8,637 sharesTotal: $18,310.44 ($2.12/share)Havencrest Healthcare PartnersSold 6,979 sharesTotal: $14,935.06 ($2.14/share)Havencrest Healthcare PartnersSold 24,915 sharesTotal: $57,304.50 ($2.30/share)View All Insider TransactionsView All Institutional Transactions TOI Stock Analysis - Frequently Asked Questions How have TOI shares performed this year? Oncology Institute's stock was trading at $2.04 at the start of the year. Since then, TOI stock has decreased by 83.6% and is now trading at $0.3340. View the best growth stocks for 2024 here. How were Oncology Institute's earnings last quarter? The Oncology Institute, Inc. (NASDAQ:TOI) posted its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by $0.07. The firm had revenue of $98.58 million for the quarter, compared to analyst estimates of $103.31 million. Oncology Institute had a negative trailing twelve-month return on equity of 109.10% and a negative net margin of 20.28%. Who are Oncology Institute's major shareholders? Oncology Institute's top institutional investors include Tiff Advisory Services LLC (1.91%) and Renaissance Technologies LLC (0.46%). Insiders that own company stock include Brad Hively, Richard A Barasch, Richy Agajanian, Matthew P Miller, Mohit Kaushal and Havencrest Healthcare Partners. View institutional ownership trends. How do I buy shares of Oncology Institute? Shares of TOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TOI) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
